These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27107424)

  • 41. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
    Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
    Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer.
    Chang J; Wang S; Zhang Z; Liu X; Wu Z; Geng R; Ge X; Dai C; Liu R; Zhang Q; Li W; Li J
    Oncotarget; 2015 Feb; 6(4):2009-22. PubMed ID: 25576915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells.
    Tomizawa F; Jang MK; Mashima T; Seimiya H
    Biochem Biophys Res Commun; 2020 Jul; 527(4):1014-1020. PubMed ID: 32439168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of CD44+CD24+ gastric cancer stem cells.
    Zhang C; Li C; He F; Cai Y; Yang H
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1679-86. PubMed ID: 21882047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD44
    Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
    Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells.
    Liu J; Xiao Z; Wong SK; Tin VP; Ho KY; Wang J; Sham MH; Wong MP
    Oncotarget; 2013 Oct; 4(10):1698-1711. PubMed ID: 24091605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.
    Yu D; Shin HS; Lee YS; Lee D; Kim S; Lee YC
    Oncol Rep; 2014 Feb; 31(2):673-8. PubMed ID: 24297371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
    Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
    Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
    Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
    Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.
    Wei WY; Yan LH; Wang XT; Li L; Cao WL; Zhang XS; Zhan ZX; Yu H; Xie YB; Xiao Q
    World J Gastroenterol; 2015 Jan; 21(2):491-501. PubMed ID: 25593464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    Li YF; Zhang HT; Xin L
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
    Kunii K; Davis L; Gorenstein J; Hatch H; Yashiro M; Di Bacco A; Elbi C; Lutterbach B
    Cancer Res; 2008 Apr; 68(7):2340-8. PubMed ID: 18381441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.
    Mathur A; Ware C; Davis L; Gazdar A; Pan BS; Lutterbach B
    PLoS One; 2014; 9(6):e98515. PubMed ID: 24968263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triterpene Acid (
    Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.
    Qian P; Li J; Zhang X; Li F; Bei S; Li H; Sun Q; Feng L
    PLoS One; 2019; 14(9):e0221640. PubMed ID: 31557193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.
    Xu Y; Yang X; Li Z; Li S; Guo S; Ismail S; Liu H; Huang Z; Zhang Z; Chen Y; Sun Q
    Oncotarget; 2017 Jan; 8(3):4888-4900. PubMed ID: 28002800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Ishimoto T; Nakagawa S; Miyake K; Nakaji Y; Tsuda Y; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Saeki H; Yoshida N; Oki E; Watanabe M; Oda Y; Bass AJ; Maehara Y; Baba H
    Oncotarget; 2016 Apr; 7(15):19748-61. PubMed ID: 26933914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated Endometrial Cancer Cells.
    Kwak Y; Cho H; Hur W; Sim T
    Mol Cancer Ther; 2015 Oct; 14(10):2292-302. PubMed ID: 26294741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.